GZMM and intrahepatic cholangiocarcinoma: Ki67 ICC showed no change in proliferation between these treatment groups (Fig. 4f, left panel), demonstrating that factors secreted by Met-1 Scr or Met-1 miR-200c cells did not impact proliferation.